| Minimal residual disease detection in childhood precursor-B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group study. | |
| | |
MedLine Citation:
|
PMID: 12886244 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Minimal residual disease (MRD) can be detected in the marrows of children undergoing chemotherapy either by flow cytometry or polymerase chain reaction. In this study, we used four-color flow cytometry to detect MRD in 1016 children undergoing therapy on Children's Oncology Group therapeutic protocols for precursor-B-cell ALL. Compliance was excellent, with follow-up samples received at the end of induction on nearly 95% of cases; sensitivity of detection at this time point was at least 1/10,000 in more than 90% of cases. Overall, 28.6% of patients had detectable MRD at the end of induction. Patients with M3 marrows at day 8 were much more likely to be MRD positive (MRD+) than those with M2 or M1 marrows. Different genetically defined groups of patients varied in their prevalence of MRD. Specifically, almost all patients with BCR-ABL had high levels of end-of-induction MRD. Only 8.4% of patients with TEL-AML1 were MRD+>0.01% compared with 20.3% of patients with trisomies of chromosomes 4 and 10. Our results show that MRD correlates with conventional measures of slow early response. However, the high frequency of MRD positivity in favorable trisomy patients suggests that the clinical significance of MRD positivity at the end of induction may not be the same in all patient groups. |
| | |
Authors:
|
M J Borowitz; D J Pullen; J J Shuster; D Viswanatha; K Montgomery; C L Willman; B Camitta; |
Related Documents
:
|
11920534 - The clinical and diagnostic relevance of cd23 expression in the chronic lymphoprolifera... 3334954 - Acute leukemia and myelodysplasia in polycythemia vera. a clinical study with long-term... 14697644 - Cytogenetic and fluorescence in situ hybridization studies in 60 patients with multiple... 3933594 - Prognostic significance of immunologic phenotype in hairy cell leukemia: does it exist? 3712564 - Bedside flexible cystoscopy: an approach to the critically ill patient. 10450194 - Vitamin b status in patients with chronic fatigue syndrome. |
Publication Detail:
|
Type: Journal Article; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Leukemia Volume: 17 ISSN: 0887-6924 ISO Abbreviation: Leukemia Publication Date: 2003 Aug |
Date Detail:
|
Created Date: 2003-07-29 Completed Date: 2003-11-06 Revised Date: 2013-03-04 |
Medline Journal Info:
|
Nlm Unique ID: 8704895 Medline TA: Leukemia Country: England |
Other Details:
|
Languages: eng Pagination: 1566-72 Citation Subset: IM |
Affiliation:
|
Johns Hopkins Medical Institutions, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Bone Marrow / pathology Child Chromosomes, Human, Pair 10 Chromosomes, Human, Pair 4 Core Binding Factor Alpha 2 Subunit Female Flow Cytometry / standards Fusion Proteins, bcr-abl / analysis Humans Male Molecular Diagnostic Techniques / standards Neoplasm, Residual / diagnosis, etiology* Oncogene Proteins, Fusion / analysis Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / diagnosis, pathology* Precursor Cell Lymphoblastic Leukemia-Lymphoma / diagnosis, pathology* Risk Factors Sensitivity and Specificity Trisomy |
| Grant Support | |
ID/Acronym/Agency:
|
R01 CA86011/CA/NCI NIH HHS; U10 29139//PHS HHS |
| Chemical | |
Reg. No./Substance:
|
0/Core Binding Factor Alpha 2 Subunit; 0/Fusion Proteins, bcr-abl; 0/Oncogene Proteins, Fusion; 0/TEL-AML1 fusion protein |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Computational analysis of flow-cytometry antigen expression profiles in childhood acute lymphoblasti...
Next Document: Clonality profile in relapsed precursor-B-ALL children by GeneScan and sequencing analyses. Conseque...